End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,290 KRW | -1.87% | -3.38% | +38.70% |
2023 | Hancom Lifecare Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2021 | Hancom Lifecare Inc. has completed an IPO in the amount of KRW 113.741798 billion. | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company sustains low margins.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 32.76 times its estimated earnings per share for the ongoing year.
- The company is highly valued given the cash flows generated by its activity.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+38.70% | 129M | - | ||
-2.54% | 187B | C+ | ||
-1.85% | 106B | C | ||
-4.26% | 66.9B | A | ||
+1.39% | 49.45B | B- | ||
+16.82% | 48B | B- | ||
+5.42% | 40.84B | B+ | ||
+3.49% | 26.48B | B | ||
+0.65% | 26.25B | A- | ||
+17.05% | 24.62B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- A372910 Stock
- Ratings Hancom Lifecare Inc.